News — Foundation Fighting Blindness

Displaying 241–250 of 508

Oct 29, 2020

Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company

In the Press
Oct 28, 2020

reVision Therapeutics Announces US FDA Grant of Rare Pediatric Disease and Orphan-Drug Designation for REV-0100 for the Treatment of Stargardt Disease

In the Press
Oct 21, 2020

SparingVision Raises €44.5 Million for Gene-Independent RP Therapy

The company is planning a clinical trial for its emerging neuroprotective treatment in 2021

Research News
Oct 20, 2020

RP Treatment Derived from Induced Pluripotent Stem Cells Advances into Clinical Trial

The stem cells were derived from mature blood cells and coaxed to become photoreceptors

Research News
Oct 19, 2020

Low Vision Resources and Rehabilitation for Retinal Degeneration Patients: A Webinar to Discuss Critical Needs and Opportunities

The free November 11 webinar for eye care professionals will convene industry experts to discuss the latest in low vision resources and rehabilitation as well as gaps in low vision care.

Foundation News
Oct 8, 2020

“Together, We’re Winning” the Fight Against Blinding Diseases

Foundation Fighting Blindness Launches New Campaign

Foundation News
Oct 8, 2020

Inherited Retinal Diseases Cost the US and Canadian Economies up to $33 Billion Annually

News
Oct 7, 2020

AGTC Joins the My Retina Tracker® Program as a New Scientific Collaborator

In the Press
Oct 6, 2020

Foundation Fighting Blindness to Host Fall National Virtual VisionWalk

The Virtual VisionWalk on October 24th will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.

Foundation News
Oct 6, 2020

Sign Up for Foundation Fighting Blindness Emails

Foundation News